Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/svn-2016-000033 http://scihub22266oqcxt.onion/10.1136/svn-2016-000033 C5435201!5435201 !28959472     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28959472 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28959472 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Stroke+Vasc+Neurol 2016 ; 1 (3 ): 115-121 Nephropedia Template TP {{tp|p=28959472 |t=2016. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? |pdf=|usr=}}{{28959472 }} gab.com Text Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard JO: Stroke Vasc Neurol http://www.kidney.de/pget.php?&tw=1&pmid=28959472 #FOAvip BACKGROUND: With the recent publication of a large clinical trial on the use of a lower dose of intravenous (IV) tissue plasminogen activator (tPA) for acute ischaemic stroke (AIS), the concept of using a different dose has been debated. We intend to review the literature on using a lower dose of IV tPA and gain a better understanding of the impact of different IV doses on the treatment of patients with AIS. METHODS: A comprehensive literature search of the related topics in PubMed, EMBASE, Web of Science and MEDLINE was carried out. Key words used include low dose IV tPA, thrombolysis, Alteplace and tPA for AIS. Findings were tabulated according to the size of the cohort studied, outcome, adverse event and level of evidence. The results of all studies using lower doses were analysed for efficacy and adverse events. RESULTS: From 1992 to 2016, there were 23 trials that included 10?950 patients published on the use of lower doses of IV tPA for AIS. Doses ranged from 0.5, 0.6, 0.75 to 0.85?mg/kg. Most were observational, retrospective and registry studies. One was a prospective open-label randomised controlled trial. 13 trials combined lower doses of IV tPA with a glycoprotein IIb/IIIa inhibitor or thrombectomy. Patients treated with lower doses of IV tPA showed a trend of lower rate of symptomatic intracranial haemorrhage and mortality at 3?months but slightly more disability. CONCLUSIONS: Lower doses of IV tPA showed less haemorrhagic events but were not more effective compared with the standard dose. The optimal low dose of IV tPA remains unclear. Patients with AIS with a high risk of developing sypmtomatic intracranial haemorrhage might benefit from lower dose IV tPA, such as 0.6?mg/kg. Twit Text FOAVip Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard ????Stroke Vasc Neurol http://www.kidney.de/pget.php?&tw=1&pmid=28959472 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28959472 #FOAvip English Wikipedia <ref>{{Cite pmid|28959472 }}</ref> Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? #MMPMID28959472 Dong Y ; Cao W ; Cheng X ; Fang K ; Wu F ; Yang L ; Xie Y ; Dong Q Stroke Vasc Neurol 2016[Sep]; 1 (3 ): 115-121 PMID28959472 show ga BACKGROUND: With the recent publication of a large clinical trial on the use of a lower dose of intravenous (IV) tissue plasminogen activator (tPA) for acute ischaemic stroke (AIS), the concept of using a different dose has been debated. We intend to review the literature on using a lower dose of IV tPA and gain a better understanding of the impact of different IV doses on the treatment of patients with AIS. METHODS: A comprehensive literature search of the related topics in PubMed, EMBASE, Web of Science and MEDLINE was carried out. Key words used include low dose IV tPA, thrombolysis, Alteplace and tPA for AIS. Findings were tabulated according to the size of the cohort studied, outcome, adverse event and level of evidence. The results of all studies using lower doses were analysed for efficacy and adverse events. RESULTS: From 1992 to 2016, there were 23 trials that included 10?950 patients published on the use of lower doses of IV tPA for AIS. Doses ranged from 0.5, 0.6, 0.75 to 0.85?mg/kg. Most were observational, retrospective and registry studies. One was a prospective open-label randomised controlled trial. 13 trials combined lower doses of IV tPA with a glycoprotein IIb/IIIa inhibitor or thrombectomy. Patients treated with lower doses of IV tPA showed a trend of lower rate of symptomatic intracranial haemorrhage and mortality at 3?months but slightly more disability. CONCLUSIONS: Lower doses of IV tPA showed less haemorrhagic events but were not more effective compared with the standard dose. The optimal low dose of IV tPA remains unclear. Patients with AIS with a high risk of developing sypmtomatic intracranial haemorrhage might benefit from lower dose IV tPA, such as 0.6?mg/kg. |*Thrombolytic Therapy/adverse effects [MESH] |Aged [MESH] |Aged, 80 and over [MESH] |Clinical Decision-Making [MESH] |Dose-Response Relationship, Drug [MESH] |Female [MESH] |Fibrinolytic Agents/*administration & dosage/adverse effects [MESH] |Humans [MESH] |Infusions, Intravenous [MESH] |Intracranial Hemorrhages/chemically induced [MESH] |Ischemic Stroke/diagnosis/*drug therapy/ethnology [MESH] |Male [MESH] |Middle Aged [MESH] |Risk Assessment [MESH] |Risk Factors [MESH]Low-dose intravenous tissue plasminogen activator for acute ischaemic (epmc).pdf DeepDyve Pubget Overpricing